These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7519405)

  • 1. Acute renal effects of neutral endopeptidase inhibition in humans.
    Schmitt F; Martinez F; Ikeni A; Savoiu C; Natov S; Laborde K; Lacour B; Grünfeld JP; Hannedouche T
    Am J Physiol; 1994 Jul; 267(1 Pt 2):F20-7. PubMed ID: 7519405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
    Dussaule JC; Grangé JD; Wolf JP; Lecomte JM; Gros C; Schwartz JC; Bodin F; Ardaillou R
    J Clin Endocrinol Metab; 1991 Mar; 72(3):653-9. PubMed ID: 1847706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats.
    Stasch JP; Knorr A; Wegner M; Hirth-Dietrich C
    Hypertens Res; 1995 Jun; 18(2):137-43. PubMed ID: 7584920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.
    Dussaule JC; Michel C; Peraldi MN; Lecomte JM; Gros C; Mignon F; Ardaillou R
    Clin Sci (Lond); 1993 Jan; 84(1):31-9. PubMed ID: 8382131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients.
    Piquard F; Richard R; Charloux A; Doutreleau S; Hannedouche T; Brandenberger G; Geny B
    J Appl Physiol (1985); 2002 Aug; 93(2):569-75. PubMed ID: 12133866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
    Varin J; Duboc D; Weber S; Fouchard J; Schwartz JC; Muffat-Joly M; Guérin F
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats.
    Park KS; Li Y; Zhang Y; Gerbes AL; Liu H; Swain MG; Lee SS
    Br J Pharmacol; 2003 May; 139(1):81-8. PubMed ID: 12746226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
    Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
    Solter P; Sisson D; Thomas W; Goetze L
    J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
    Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
    J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
    Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
    Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.
    Kimmelstiel CD; Perrone R; Kilcoyne L; Souhrada J; Udelson J; Smith J; de Bold A; Griffith J; Konstam MA
    Cardiology; 1996; 87(1):46-53. PubMed ID: 8631044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients.
    Lipkin GW; Thuraisingham R; Dawnay AB; Harwood SM; Raine AE
    Transplantation; 1997 Oct; 64(7):1007-17. PubMed ID: 9381523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
    Swärd K; Valsson F; Sellgren J; Ricksten SE
    Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of nitric oxide to diuretic and natriuretic effects of renal kinins in normotensive rats.
    Takagawa Y; Ura N; Nanba M; Agata J; Higashiura K; Torii T; Takada M; Shimamoto K
    Hypertens Res; 1999 Jul; 22(2):129-34. PubMed ID: 10487329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enkephalinase inhibition increases plasma atrial natriuretic peptide levels, glomerular filtration rate, and urinary sodium excretion in rats with reduced renal mass.
    Lafferty HM; Gunning M; Silva P; Zimmerman MB; Brenner BM; Anderson S
    Circ Res; 1989 Sep; 65(3):640-6. PubMed ID: 2548762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic response to neutral endopeptidase inhibition is blunted by enalapril in healthy men.
    Motwani JG; Lang CC; Cramb G; Struthers AD
    Hypertension; 1995 Apr; 25(4 Pt 1):637-42. PubMed ID: 7721409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
    J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.